{
    "title": "Novartis sales, profits rise in first quarter on COVID-19 buying rush",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8263791/Novartis-posts-Q1-sales-profit-beat-COVID-19-spurs-prescriptions.html",
    "date": "2020-04-28",
    "keywords": [
        "revenue",
        "drug",
        "hydroxychloroquine",
        "miller",
        "coronavirus",
        "crisis",
        "income",
        "analyst",
        "forecast",
        "poll",
        "result",
        "growth",
        "healthcare",
        "narasimhan",
        "gamechanger",
        "covid19",
        "medicine",
        "climb",
        "drugmaker",
        "company",
        "tuesday",
        "average",
        "mid",
        "percentage",
        "singledigit",
        "operating",
        "profit",
        "executive",
        "vas",
        "outlook",
        "rush",
        "performance",
        "call",
        "pandemic",
        "division",
        "skin",
        "cosentyx",
        "jump",
        "heart",
        "failure",
        "unit",
        "muscle",
        "europe",
        "zuercher",
        "overweight",
        "rating",
        "novartis",
        "trial",
        "march",
        "president",
        "trump",
        "lack",
        "evidence",
        "advocacy",
        "action",
        "pressure",
        "hope",
        "science",
        "world",
        "unaware",
        "industry",
        "dose",
        "setting",
        "system",
        "reason",
        "summer",
        "data",
        "reporting",
        "john",
        "michael",
        "edmund",
        "blair"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}